University hospitals Schleswig-Holstein, Cologne and Würzburg officially joined the HiGHmed consortium
After the successful completion of a formal application and review process, September 2018 saw the University Hospital Schleswig-Holstein and Kiel University, the University Hospital Cologne and the University Hospital Würzburg and Medical Faculty of the University Würzburg join the HiGHmed consortium. Over the next 3.5 years, the University Hospital Schleswig-Holstein and Kiel University will receive around €2.8 Mio, the University Hospital Cologne around €2.7 Mio and the University and University Hospital of Würzburg around €2.7 Mio from the German Federal Ministry of Education and Research (BMBF) to strengthen medical informatics. Each site will establish a data integration centre to promote multi-site data exchange and contribute their proven competence to the medical use cases cardiology and oncology.
The University Hospital Schleswig-Holstein campus Kiel excels through strength in heart failure research and treatment in the department of cardiology, angiology and intensive care medicine. It has wide-ranging expertise in the management of large heart failure patient cohorts and maintains an extensive heart failure biobank. Furthermore, it is the local site of the German Centre for Cardiovascular Diseases and participates in the installation of large national and international heart failure registries.
For more information, please refer to:
Press release from the University Hospital Schleswig-Holstein dated August 22nd 2018
The University Hospital Würzburg and Medical Faculty will contribute outstanding expertise in patient data management and data sharing, through invaluable experience from participating in national and European biobanking networks, as well as translational research networks, such as the Comprehensive Heart Failure Centre Würzburg, the Competence Network Heart Failure and the Comprehensive Cancer Centre Initiative.
The University Clinic Cologne is renowned for excellent research in precision oncology and will contribute to individualise cancer care. Data from additional hepatobiliary cancer patients will enrich the value of cross-institutional data sharing in improving patient outcome. The University Clinic Cologne will also contribute its extensive expertise in computational life sciences to deepen the understanding of molecular disease mechanism for oncology research.